Close

ICON Recognised as Clinical Research Company of the year

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift,...

The Benefits of Virtual GP Insurance: A Game Changer for Modern Healthcare

In today’s fast-paced world, accessing healthcare quickly and efficiently...

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new...

Who Is and Isn’t a Good Candidate for LASIK Surgery?

In the decades since its FDA approval, LASIK eye...
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that it has been named “Clinical Research Company of the year” at the annual PharmaTimes awards.

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that it has been named “Clinical Research Company of the year” at the annual PharmaTimes awards.

The PharmaTimes awards, which were announced at a ceremony in London on Thursday, 15th January, recognise and reward excellence in pharmaceutical clinical development. In total, ICON had over thirty staff short-listed as finalists across different categories, the highest number from any organisation.

ICON Clinical Research won gold, silver and bronze in both the Clinical Research Team of the Year and Clinical Research Associate of the Year categories. In addition to this recognition, ICON also received a bronze award in the Project Management category.

Alan Morgan, Chief Operating Officer, ICON Clinical Research, commented: We are delighted with our success at the PharmaTimes awards, as it recognises the outstanding contribution that our people have made to the overall success of the organisation.

Latest stories

Related stories

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift,...

The Benefits of Virtual GP Insurance: A Game Changer for Modern Healthcare

In today’s fast-paced world, accessing healthcare quickly and efficiently...

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new...

Who Is and Isn’t a Good Candidate for LASIK Surgery?

In the decades since its FDA approval, LASIK eye...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back